SciELO - Scientific Electronic Library Online

 
vol.140 número5Utilidad de la tomografía por emisión de positrones (PET) en el cáncer pulmonar índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Gaceta médica de México

versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813

Resumen

GARZA-MADRID, Marcos E; BORBOLLA-ESCOBOZA, José R  y  LOPEZ-HERNANDEZ, Manuel A. Autologous Bone Marrow Transplantation as a Treatment for Autoimmune Disease: Mechanisms and Results. Gac. Méd. Méx [online]. 2004, vol.140, n.5, pp.531-539. ISSN 2696-1288.

Autoimmune diseases are characterized by immune response against self antigens. One of the current research interests in this field is oriented toward development of tolerance. One of the newest options in the search for tolerance is autologous bone marrow transpiantation: a variant of bone marrow transplant in which the patient's own hematopoietic stem cells are reinfused after myeloablative therapy. The idea of using bone marrow transplant in treatment of autoimmune diseases derived from observing remission in autoinmune diseases in patients transplanted due to coexisting neoplastic disease. Although an isolated initial report of bone marrow transplant as treatment for autoimmune disease questioned the utility of this procedure, over all, results are encouraging. To compile information in a programmed and systematic manner, it is necessary to send more patients in all stages of immune diseases to specialized centers to be included in large multicenter randomized trials. In time, the role for this procedure in autoimmune diseases will become clear.

Palabras llave : Autoimmune diseases; bone marrow transplant; lupues; arthritis; multiple slcerosis; systemic sclerosis.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons